1. Operating on Jehovah’s Witnesses: A Challenging Surgical Issue
- Author
-
Gregory Kouraklis, Zoe Garoufalia, Apostolos Aggelis, Efstathios Antoniou, and C. Vagianos
- Subjects
medicine.medical_specialty ,Blood transfusion ,Anemia ,business.industry ,General surgery ,medicine.medical_treatment ,05 social sciences ,Religious studies ,Cancer ,050109 social psychology ,Retrospective cohort study ,General Medicine ,medicine.disease ,University hospital ,humanities ,Clinical Practice ,03 medical and health sciences ,0302 clinical medicine ,medicine ,0501 psychology and cognitive sciences ,030212 general & internal medicine ,business ,General Nursing ,Whole blood ,Healthcare system - Abstract
Blood transfusion is often utilized in surgery. Greece is the second-highest consumer of blood components in Europe. It has been shown that at least half of all transfusions are unnecessary and could be avoided. Jehovah's Witnesses (JWs) are a Christian religion that do not accept transfusion of whole blood or the four primary components of blood-namely, red blood cells, white blood cells, platelets, and plasma. This a retrospective study from September of 2015 to January of 2018, analyzing all JWs who underwent an elective operation at the Second Department of Propaedeutic Surgery in Laiko University Hospital. Twenty-nine (Rogers et al. in NCCN Guidelines Version 2.2014 Cancer- and Chemotherapy-Induced Anemia. NCCN Clinical Practice Guidelines in Oncology. National Comprehensive Cancer Network, Fort Washington, 2013) JW patients, 23 females (74.1%) and eight males, were operated on during the aforementioned period. The median ASA score was 1 (range 1-3), and only two of the patients needed postoperative monitoring in the ICU. Almost half of the patients (45.1%) needed iron infusion and EPO injection preoperatively. Two patients presented with postoperative complications, with no postoperative deaths. In conclusion, we found that surgery, in our small group of JW patients, was safe and successful despite the lack of blood transfusion. Techniques developed to treat JW patients should be more widely used to improve clinical outcomes and reduce costs to the healthcare system.
- Published
- 2021
- Full Text
- View/download PDF